• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非转移性头颈部横纹肌肉瘤患者的非手术治疗与手术治疗的等效性:一项基于 SEER 的研究。

Non-inferior efficacy of non-surgical treatment to surgical treatment in patients with nonmetastatic head and neck rhabdomyosarcoma: a SEER-based study.

机构信息

Department of Radiation and Medical Oncology, Hubei Key Laboratory of Tumour Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University, Wuhan, China.

Department of Medical Record Management, Beijing South Medical District, Chinese PLA General Hospital, Beijing, China.

出版信息

Clin Transl Oncol. 2023 Jun;25(6):1779-1792. doi: 10.1007/s12094-023-03076-x. Epub 2023 Jan 14.

DOI:10.1007/s12094-023-03076-x
PMID:36640207
Abstract

PURPOSE

Head and neck rhabdomyosarcoma (HNRMS) is a rare but aggressive malignant neoplasm. Given the young patient age and critical anatomy of the head and neck, performing surgery on the primary tumor still remains debatable. This study aimed to evaluate the impact of the non-surgery-based treatment versus surgery-based treatment on patients with nonmetastatic HNRMS.

METHODS

Patients diagnosed with nonmetastatic HNRMS between 2004 and 2015 from the Surveillance, Epidemiology, and End Results (SEER) database were enrolled in our study. Inverse probability treatment weighting (IPTW) method was employed to balance confounding factors between surgery and non-surgery groups. Kaplan-Meier methods and COX regression analyses were used to analyze survival outcomes of overall survival (OS) and cancer-specific survival (CSS). Prognostic nomogram was established to predict survival.

RESULTS

A total of 260 eligible patients were extracted from the SEER database. Kaplan-Meier survival curves revealed that there was no significant difference in OS and CSS between the surgery and non-surgery groups both before and after IPTW (p > 0.05). Cox regression analyses and IPTW-adjusted Cox regression analyses for both OS and CSS showed similar survival between the two groups. Prognostic factors were explored and a nomogram for patients in the surgery group was constructed. Risk stratification based on the nomogram indicated that patients in surgery-high-risk group did not benefit from primary surgery. While those in surgery-low-risk group had an equal survival outcome to those in non-surgery group.

CONCLUSIONS

Our study revealed that compared to patients receiving surgery, those not receiving surgery had similar survival outcomes for nonmetastatic HNRMS. Our established nomogram may serve as a practical tool for individual prognostic evaluations.

摘要

目的

头颈部横纹肌肉瘤(HNRMS)是一种罕见但具有侵袭性的恶性肿瘤。鉴于患者年龄较小且头颈部解剖结构关键,对原发性肿瘤进行手术仍然存在争议。本研究旨在评估非手术治疗与手术治疗对非转移性 HNRMS 患者的影响。

方法

本研究纳入了 2004 年至 2015 年期间来自监测、流行病学和最终结果(SEER)数据库的诊断为非转移性 HNRMS 的患者。采用逆概率治疗加权(IPTW)方法平衡手术组和非手术组之间的混杂因素。Kaplan-Meier 方法和 COX 回归分析用于分析总生存率(OS)和癌症特异性生存率(CSS)的生存结果。建立预后列线图以预测生存。

结果

从 SEER 数据库中提取了 260 名符合条件的患者。Kaplan-Meier 生存曲线显示,在 IPTW 前后,手术组和非手术组的 OS 和 CSS 均无显著差异(p>0.05)。COX 回归分析和 IPTW 调整的 COX 回归分析对于 OS 和 CSS 均显示两组之间的生存相似。探讨了预后因素,并为手术组患者构建了列线图。基于列线图进行风险分层表明,手术高风险组的患者并未从原发性手术中获益。而手术低风险组的患者与非手术组的生存结局相当。

结论

与接受手术的患者相比,本研究显示未接受手术的非转移性 HNRMS 患者具有相似的生存结果。我们建立的列线图可能成为个体预后评估的实用工具。

相似文献

1
Non-inferior efficacy of non-surgical treatment to surgical treatment in patients with nonmetastatic head and neck rhabdomyosarcoma: a SEER-based study.非转移性头颈部横纹肌肉瘤患者的非手术治疗与手术治疗的等效性:一项基于 SEER 的研究。
Clin Transl Oncol. 2023 Jun;25(6):1779-1792. doi: 10.1007/s12094-023-03076-x. Epub 2023 Jan 14.
2
Nomogram to predict prognosis of head and neck rhabdomyosarcoma patients in children and adolescents.预测儿童和青少年头颈部横纹肌肉瘤患者预后的列线图。
Front Oncol. 2024 Mar 25;14:1378251. doi: 10.3389/fonc.2024.1378251. eCollection 2024.
3
Establishment of prognostic nomogram for T1N0M0 glottic squamous cell carcinoma: an SEER database analysis.T1N0M0声门鳞状细胞癌预后列线图的建立:一项监测、流行病学和最终结果(SEER)数据库分析
Eur Arch Otorhinolaryngol. 2023 May;280(5):2397-2410. doi: 10.1007/s00405-022-07763-3. Epub 2022 Dec 1.
4
Development and validation of a nomogram to predict the prognosis of patients with gastric cardia cancer.开发和验证一个列线图模型以预测胃贲门癌患者的预后。
Sci Rep. 2020 Aug 24;10(1):14143. doi: 10.1038/s41598-020-71146-z.
5
Comparing the characteristics and predicting the survival of patients with head and neck melanoma versus body melanoma: a population-based study.比较头颈部黑色素瘤与身体黑色素瘤患者的特征并预测其生存情况:一项基于人群的研究。
BMC Cancer. 2021 Apr 16;21(1):420. doi: 10.1186/s12885-021-08105-y.
6
Prognostic Factors and a Nomogram Predicting Overall Survival and Cancer-Specific Survival for Patients with Collecting Duct Renal Cell Carcinoma.预测肾集合管细胞癌患者总生存和癌症特异性生存的预后因素和列线图。
Biomed Res Int. 2021 Nov 11;2021:6736008. doi: 10.1155/2021/6736008. eCollection 2021.
7
A novel nomogram and risk classification system for predicting overall survival in head and neck squamous cell cancer with distant metastasis at initial diagnosis.一种用于预测初诊时伴有远处转移的头颈部鳞状细胞癌总生存期的新型列线图和风险分类系统。
Eur Arch Otorhinolaryngol. 2023 Mar;280(3):1467-1478. doi: 10.1007/s00405-022-07716-w. Epub 2022 Oct 31.
8
Establishment and validation of systematic prognostic nomograms in patients over 60 years of age with osteosarcoma: A multicenter external verification study.60 岁以上骨肉瘤患者的系统预后列线图的建立和验证:一项多中心外部验证研究。
Cancer Med. 2023 Apr;12(8):9589-9603. doi: 10.1002/cam4.5736. Epub 2023 Mar 29.
9
Construction and validation of a prognostic nomogram in metastatic breast cancer patients of childbearing age: A study based on the SEER database and a Chinese cohort.育龄期转移性乳腺癌患者预后列线图的构建与验证:一项基于监测、流行病学和最终结果(SEER)数据库及中国队列的研究
Front Oncol. 2022 Nov 25;12:999873. doi: 10.3389/fonc.2022.999873. eCollection 2022.
10
Development and validation of a prognostic nomogram for adult patients with renal sarcoma: A retrospective study based on the SEER database.基于 SEER 数据库的回顾性研究:建立和验证用于预测成人肾肉瘤患者预后的列线图
Front Public Health. 2022 Sep 12;10:942608. doi: 10.3389/fpubh.2022.942608. eCollection 2022.

引用本文的文献

1
Nomogram to predict prognosis of head and neck rhabdomyosarcoma patients in children and adolescents.预测儿童和青少年头颈部横纹肌肉瘤患者预后的列线图。
Front Oncol. 2024 Mar 25;14:1378251. doi: 10.3389/fonc.2024.1378251. eCollection 2024.
2
Dynamic Survival Risk Prognostic Model and Genomic Landscape for Atypical Teratoid/Rhabdoid Tumors: A Population-Based, Real-World Study.非典型畸胎样/横纹肌样瘤的动态生存风险预后模型与基因组图谱:一项基于人群的真实世界研究
Cancers (Basel). 2024 Mar 5;16(5):1059. doi: 10.3390/cancers16051059.
3
Comparison of Definitive Radiotherapy-Based Treatment and Surgical-Based Treatment for Locally Advanced Head and Neck Soft Tissue Sarcoma.

本文引用的文献

1
Therapy and prognostic significance of regional lymph node involvement in embryonal rhabdomyosarcoma: a report from the European paediatric Soft tissue sarcoma Study Group.胚胎性横纹肌肉瘤区域性淋巴结受累的治疗和预后意义:来自欧洲儿科软组织肉瘤研究组的报告。
Eur J Cancer. 2022 Sep;172:119-129. doi: 10.1016/j.ejca.2022.05.033. Epub 2022 Jun 25.
2
Adolescents and young adults with rhabdomyosarcoma treated in the European paediatric Soft tissue sarcoma Study Group (EpSSG) protocols: a cohort study.在欧洲儿科软组织肉瘤研究组(EpSSG)方案中治疗的横纹肌肉瘤青少年和年轻成年人:一项队列研究。
Lancet Child Adolesc Health. 2022 Aug;6(8):545-554. doi: 10.1016/S2352-4642(22)00121-3. Epub 2022 Jun 9.
3
基于根治性放疗的治疗与基于手术的治疗对局部晚期头颈部软组织肉瘤的疗效比较
J Clin Med. 2023 Apr 24;12(9):3099. doi: 10.3390/jcm12093099.
Locoregional Control and Survival in Children, Adolescents, and Young Adults With Localized Head and Neck Alveolar Rhabdomyosarcoma-The French Experience.
法国经验:儿童、青少年和年轻成人局限性头颈部肺泡横纹肌肉瘤的局部区域控制与生存情况
Front Pediatr. 2022 Feb 4;9:783754. doi: 10.3389/fped.2021.783754. eCollection 2021.
4
An introduction to inverse probability of treatment weighting in observational research.观察性研究中治疗权重逆概率法简介。
Clin Kidney J. 2021 Aug 26;15(1):14-20. doi: 10.1093/ckj/sfab158. eCollection 2022 Jan.
5
Evolving classification of rhabdomyosarcoma.横纹肌肉瘤的分类演变。
Histopathology. 2022 Jan;80(1):98-108. doi: 10.1111/his.14449.
6
Non-parameningeal head and neck rhabdomyosarcoma in children, adolescents, and young adults: Experience of the European paediatric Soft tissue sarcoma Study Group (EpSSG) - RMS2005 study.儿童、青少年和青年非生殖细胞性头颈部横纹肌肉瘤:欧洲儿科软组织肉瘤研究组(EpSSG)- RMS2005 研究的经验。
Eur J Cancer. 2021 Jul;151:84-93. doi: 10.1016/j.ejca.2021.04.007. Epub 2021 May 7.
7
Role of Surgery in Rhabdomyosarcoma of the Head and Neck in Children.头颈部横纹肌肉瘤患儿的外科治疗作用。
Laryngoscope. 2021 Mar;131(3):E984-E992. doi: 10.1002/lary.28785. Epub 2020 Jul 20.
8
Current and Future Treatment Strategies for Rhabdomyosarcoma.横纹肌肉瘤的当前及未来治疗策略
Front Oncol. 2019 Dec 20;9:1458. doi: 10.3389/fonc.2019.01458. eCollection 2019.
9
Soft tissue sarcoma in children, adolescents and young adults: Outcomes according to compliance with international initial care guidelines.儿童、青少年和青年软组织肉瘤:根据国际初始治疗指南的依从性的结果。
Eur J Surg Oncol. 2020 Jul;46(7):1277-1286. doi: 10.1016/j.ejso.2019.11.518. Epub 2019 Nov 30.
10
Prognostic Factors and Treatment Outcomes of Adult Patients With Rhabdomyosarcoma After Multimodality Treatment.多模式治疗后成人横纹肌肉瘤患者的预后因素及治疗结果
Anticancer Res. 2019 Mar;39(3):1355-1364. doi: 10.21873/anticanres.13249.